Evidence map›Paper›PMID 35050366›Full record

ReviewDiabetes care2022

Controversies Around the Measurement of Blood Ketones to Diagnose and Manage Diabetic Ketoacidosis.

Eric S Kilpatrick, Alexandra E Butler, Linda Ostlundh, Stephen L Atkin, David B Sacks

Erratum issuedOpen access · bronzeAbstract readReview
In one paragraph

Review in Diabetes care, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
5.2field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 30 citations in OpenAlex.

  1. Review
  2. Sex-Specific Determinants of the Ketone Body β-Hydroxybutyrate in the General Population.The Journal of clinical endocrinology and metabolism · 2026
    Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Update on Measuring Ketones.Journal of diabetes science and technology · 2024
    Review
  13. Article
  14. Observational
  15. Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Hospital Diabetes Meeting 2022.Journal of diabetes science and technology · 2022
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 4 countries.

Eric S KilpatrickDepartment of Clinical Biochemistry, Manchester Royal Infirmary, Manchester, U.K.ORCID 0000-0003-1676-0461
Alexandra E ButlerDepartment of Postgraduate Studies and Research, Royal College of Surgeons in Ireland, Medical University of Bahrain, Busaiteen, Bahrain.ORCID 0000-0002-5762-3917
Linda OstlundhCollege of Medicine and Health Sciences, United Arab Emirates University, Al Ain.
Stephen L AtkinDepartment of Postgraduate Studies and Research, Royal College of Surgeons in Ireland, Medical University of Bahrain, Busaiteen, Bahrain.
David B SacksNational Institutes of Health, Bethesda, MD.
Royal College of Surgeons in Ireland - Bahrain · BHManchester Royal Infirmary · GBNational Institutes of Health · USUnited Arab Emirates University · AE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The measurement of blood ketones in preference to urine ketones has become a well-established tool in the diagnosis and management of diabetic ketoacidosis (DKA). However, there remains considerable disparity between diabetes guidelines regarding if, how, and when this test should be used. While recent guidelines now mainly emphasize blood measurement, several issues nonetheless remain. Many laboratories still measure blood ketones using a semiquantitative test that does not measure the predominant ketone, β-hydroxybutyrate (BOHB), which may hinder patient management. Even when BOHB is measured, the evidence for cutoffs used in DKA diagnosis or exclusion is limited, while its use in gauging severity, treatment progress, and resolution is not fully clear. Lastly, although employing point-of-care meters instead of a laboratory for BOHB measurement brings undoubted benefits, this approach has its own challenges. This article provides a perspective on these topics to complement current recommendations and to suggest how future research may improve its use in the DKA context.

Indexed as

Diabetes MellitusDiabetic Ketoacidosis3-Hydroxybutyric AcidHumansKetonesPoint-of-Care Systems3-Hydroxybutyric AcidKetones

Identifiers

PMID35050366
PMCPMC8897555
OpenAlexW4206613598

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.